Genix Pharmaceuticals Corporation (GENPF)
OTCMKTS · Delayed Price · Currency is USD
0.0400
+0.0140 (53.85%)
At close: Jun 17, 2024

Genix Pharmaceuticals Statistics

Total Valuation

GENPF has a market cap or net worth of 1.28 million. The enterprise value is 1.93 million.

Market Cap 1.28M
Enterprise Value 1.93M

Important Dates

The next estimated earnings date is Thursday, June 26, 2025.

Earnings Date Jun 26, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 59.22M
Shares Outstanding n/a
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 47.83M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 465.22
PB Ratio -1.43
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -23.02
EV / Sales n/a
EV / EBITDA 13.97
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.04

Current Ratio 0.04
Quick Ratio 0.01
Debt / Equity n/a
Debt / EBITDA 4.73
Debt / FCF n/a
Interest Coverage -2.61

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -146.07%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 27.45%
Revenue Per Employee 1
Profits Per Employee -21
Employee Count 4,000
Asset Turnover 0.03
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +6.95% in the last 52 weeks. The beta is 0.35, so GENPF's price volatility has been lower than the market average.

Beta (5Y) 0.35
52-Week Price Change +6.95%
50-Day Moving Average 0.11
200-Day Moving Average n/a
Relative Strength Index (RSI) 46.49
Average Volume (20 Days) 11,817

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.24

Income Statement

In the last 12 months, GENPF had revenue of 2,750 and -83,874 in losses. Loss per share was -0.00.

Revenue 2,750
Gross Profit -124,888
Operating Income -244,787
Pretax Income -83,874
Net Income -83,874
EBITDA 132,664
EBIT -244,787
Loss Per Share -0.00
Full Income Statement

Balance Sheet

The company has 2,199 in cash and 627,588 in debt, giving a net cash position of -625,390.

Cash & Cash Equivalents 2,199
Total Debt 627,588
Net Cash -625,390
Net Cash Per Share n/a
Equity (Book Value) -891,622
Book Value Per Share -0.02
Working Capital -896,108
Full Balance Sheet

Cash Flow

Operating Cash Flow -143,630
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -8,901.35%
Pretax Margin -3,049.96%
Profit Margin n/a
EBITDA Margin 4,824.27%
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

GENPF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -6.56%
FCF Yield n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

GENPF has an Altman Z-Score of -351.81. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -351.81
Piotroski F-Score n/a